Digest Network Come funziona
Network
/
Società
Di
Non verificato

Diamyd Medical AB

Di cosa scriviamo

EconomiaFarmaceuticaFinanzaSanitàStart-up

12 comunicati stampa

Guarda tutti i comunicati
23/03/2026
Salute
Fitness
Finanza
Risparmio/Affari personali
Fondi di investimento
Medicina - Varie
Ecologia/Salute ambientale
Agricoltura
Diamyd Medical enters into equity financing agreements with new U.S. sector specialist investors for up to USD 125 million and announces full enrollment in Phase 3 trial
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
21/04/2025
Farmaceutica
Sanità
Media
Comunicazione
Economia
Start-up
Diamyd Medical highlights opportunity in Type 1 Diabetes prevention, adult-onset market, and upcoming Phase 3 readout
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
12/02/2025
Farmaceutica
Sanità
Banca
Finanza
Mutui
Risparmio/Affari personali
Leasing
Gestione dei titoli obbligazionari
Fondi di investimento
Euro-obbligazioni
Diamyd Medical announces expanded financial support from Breakthrough T1D
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
13/01/2025
Farmaceutica
Sanità
Economia
Start-up
Biologia
Diamyd Medical updates U.S. market potential for Diamyd®
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
10/01/2025
Farmaceutica
Sanità
Economia
Start-up
Finanza
Biologia
Diamyd Medical confirms key advances toward Accelerated Approval for Diamyd® following FDA Type C Meeting
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
13/12/2024
Farmaceutica
Sanità
Diamyd Medical Aligns with FDA on Key Elements for an Accelerated Approval Process
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
21/11/2024
Farmaceutica
Sanità
Economia
Start-up
Diamyd Medical hits a recruitment milestone in DIAGNODE-3 Phase 3 trial
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
06/11/2024
Farmaceutica
Sanità
In-depth analysis showing robust Diamyd® treatment effects across clinical trials to be shared at the 2024 IDS Diabetes Congress
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
09/09/2024
Farmaceutica
Sanità
Economia
Start-up
Diamyd Medical to pursue accelerated approval pathway for Type 1 Diabetes precision medicine
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0
30/07/2024
Sanità
Diamyd Medical Announces Positive Interim Analysis Results for Phase 3 Trial in Type 1 Diabetes
Fonte
Diamyd Medical AB
Emittente
PR News Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0